Related Experiment Video
Updated: Jul 31, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers
Alisa B Kachikis1, Hye Cho2, Janet A Englund3
1Department of Obstetrics & Gynecology, University of Washington, 1959 Northeast Pacific Street, Box 356460, Seattle, WA 98195, USA.
Insights
Respiratory syncytial virus (RSV) poses a significant health risk, especially to infants and older adults. Research is expanding to include RSV infection during pregnancy and developing new prevention strategies like vaccines and monoclonal antibodies.
Area of Science:
- Virology and Epidemiology
- Maternal and Child Health
Background:
- Respiratory syncytial virus (RSV) is a major cause of illness and death in infants, older adults, and immunocompromised individuals.
- Current understanding of RSV infection during pregnancy is limited, highlighting a critical knowledge gap.
- Existing research focuses on high-risk populations, necessitating broader investigation.
Purpose of the Study:
- To underscore the need for more data on respiratory syncytial virus (RSV) infection in pregnant individuals.
- To highlight the importance of maternal immunization and other preventive measures.
- To inform future research directions for RSV prevention in vulnerable populations.
Main Methods:
- Review of existing literature on RSV epidemiology and impact.
- Analysis of current trends in vaccine and monoclonal antibody development.
- Identification of research gaps concerning pregnancy and RSV.
Main Results:
- RSV significantly impacts infant and elderly populations, contributing to substantial morbidity and mortality.
- Data on RSV infection in pregnant women remain scarce.
- Advancements in vaccine technology and monoclonal antibody therapies are progressing.
Conclusions:
- Further research into RSV infection during pregnancy is crucial.
- Development of maternal vaccines and antibody-based prevention holds promise.
- Comprehensive strategies are needed to protect all vulnerable groups from RSV.
Abstract:
Respiratory syncytial virus (RSV) infection is a significant cause of morbidity and mortality among infants aged younger than 1 year, adults aged 65 years or older, and immunocompromised persons. Limited data exist on RSV infection in pregnancy and further research is needed. Strides are being made to develop vaccines, including vaccines for maternal immunization, as well as monoclonal antibodies for disease prevention.
More Related Videos
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

